Skip to main content
Log in

Differential response of ferrets to infection with virulent and avirulent influenza viruses: A possible marker of virus attenuation

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

The behaviour of three recombinant strains of influenza virus A/England/939/69 and A/PR/8, together with the parent A/England/939/69 strain, all of known virulence to man, were examined in ferrets. For the virulent A/England/939/69 strain, the peak temperature response and the time of peak virus excretion occurred 48 hours post-infection, and peak protein and secretory antibody responses occurred on days 7 and 9. In contrast, the peak temperatures and maximum virus excretions for the recombinant attenuated viruses, clones 7 and 6a, occurred on day 3 and 6, and the maximum protein and nasal antibody responses on days 9 and 11, respectively. Although the peak responses for these strains were distinct, the magnitudine of the symptoms was comparable. Similar studies with the over attenuated clone 64C virus showed a milder infection. In addition, the maximum temperature response and virus excretion occurred on day 5 post-infection, and the maximum nasal protein concentration was found on day 11 after virus infection. These differences between the strains were only apparent when animals were given an inoculum of 10 EID50; no differences were observed between the four strains when larger inocula were used. The results suggest that virus infection of ferrets was distinct for strains of differing human virulence, and that the ferret model may provide a test for virulence for man.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aymard-Henry, M., Coleman, M. T., Dowdle, W. R.: Influenza virus neuraminidase and neuraminidase inhibition test procedures. Bull. W.H.O.48, 199 (1973).

    Google Scholar 

  2. Beare, A. S., Hobson, D., Reed, S. E., Tyrrell, D. A. J.: A comparison of live and killed influenza virus vaccines. Lancetii, 418–420 (1968).

    Google Scholar 

  3. Beare, A. S., Bynoe, M. L., Tyrrell, D. A. J.: Investigation into the attenuation of influenza viruses by serial passage. Brit. med. J.4, 482 (1968).

    Google Scholar 

  4. Beare, A. S., Hall, T. S.: Recombinant influenza A viruses as live vaccines for man. Lancetii, 1271 (1971).

    Google Scholar 

  5. Beare, A. S., Craig, J. W., Schild, G. C.: Trials in man with live recombinants made from A/PR/8/34 (H0N1) and wild H3N2 influenza viruses. Lancet1975, 729.

  6. Fazekas de St. Groth, S., Witchell, J., Lafferty, K. J.: An improved assay for neutralization antibodies against influenza viruses. J. Hyg. (Camb.)56, 415 (1958).

    Google Scholar 

  7. Hara, K., Beare, A. S., Tyrrell, D. A. J.: Growth and pathogenicity of influenza viruses in organ cultures of ciliated epithelium. Arch. ges. Virusforsch.44, 227 (1973).

    Google Scholar 

  8. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the folin phenol reagent. J. biol. Chem.193, 265 (1951).

    Google Scholar 

  9. Maasaab, H. F., Kendall, A. P., Davenport, F. M.: Hybrid formation of influenza virus at 25° C. Fed. Proc.30, 413 (1971).

    Google Scholar 

  10. McCahon, D., Schild, G. C.: Segregation of antigenic biological characteristics during influenza virus recombination. J. gen. Virol.15, 73 (1972).

    Google Scholar 

  11. Michaels, R. H., Mahmud, M. I. A., Coup, A. J., Jennings, R., Potter, C. W.: Influenza virus infection in newborn rats: a possible marker of attenuation for man. (In press.)

  12. Mostow, S. R., Tyrrell, D. A. J.: Detection of attenuation of recombinant influenza viruses “in vitro”. Lancetii, 116 (1972).

    Google Scholar 

  13. Mostow, S. R., Tyrrell, D. A. J.: The behaviour “in vitro” of attenuation of recombinant influenza viruses. Arch. ges. Virusforsch.43, 385 (1973).

    Google Scholar 

  14. Murphy, B. R., Chalhub, E. G., Nusinoff, S. R., Chanock, R. M.: Temperature-sensitive mutants of influenza virus. II. Attenuation ofts recombinants for man. J. inf. Dis.126, 170 (1972).

    Google Scholar 

  15. Potter, C. W., Oxford, J. S., Shore, S. L., McLaren, C., Stuart-Harris, C. H.: Immunity to influenza in ferrets I. Response to live and killed virus. Brit. J. exp. Pathol.53, 153 (1972).

    Google Scholar 

  16. Potter, C. W., McLaren, C., Jennings, R.: Assessment of resistance to influenza virus infection in animal models. Dev. biol. Stand.28, 307 (1975).

    Google Scholar 

  17. Prinzie, A., Delem, A., Huygelen, C.: Protective efficacy of a live attenuated, influenza virus vaccine (“Alice” strain). Postgrad. med. J.52, 395 (1976).

    Google Scholar 

  18. Toms, G. L., Bird, R. A., Kingsman, S. M., Sweet, C., Smith, H.: The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man. Brit. J. exp. Pathol.57, 37 (1976).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

With 3 Figures

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fenton, R.J., Jennings, R. & Potter, C.W. Differential response of ferrets to infection with virulent and avirulent influenza viruses: A possible marker of virus attenuation. Archives of Virology 55, 55–66 (1977). https://doi.org/10.1007/BF01314479

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01314479

Keywords

Navigation